3.15
price down icon2.48%   -0.08
 
loading
Lipocine Inc stock is traded at $3.15, with a volume of 21,567. It is down -2.48% in the last 24 hours and down -1.25% over the past month. Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
See More
Previous Close:
$3.23
Open:
$3.2924
24h Volume:
21,567
Relative Volume:
0.43
Market Cap:
$16.85M
Revenue:
-
Net Income/Loss:
$-16.35M
P/E Ratio:
-1.0328
EPS:
-3.05
Net Cash Flow:
$-11.88M
1W Performance:
-8.43%
1M Performance:
-1.25%
6M Performance:
-27.08%
1Y Performance:
-37.99%
1-Day Range:
Value
$3.12
$3.2924
1-Week Range:
Value
$3.12
$3.5288
52-Week Range:
Value
$2.6838
$6.1683

Lipocine Inc Stock (LPCN) Company Profile

Name
Name
Lipocine Inc
Name
Phone
801 994 7383
Name
Address
675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
Name
Employee
16
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
LPCN's Discussions on Twitter

Compare LPCN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LPCN
Lipocine Inc
3.15 17.28M 0 -16.35M -11.88M -3.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Lipocine Inc Stock (LPCN) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-24-21 Initiated Cantor Fitzgerald Overweight
Dec-10-20 Upgrade Ladenburg Thalmann Neutral → Buy
Jan-12-18 Reiterated H.C. Wainwright Buy
Jan-11-18 Downgrade Canaccord Genuity Buy → Hold
Dec-08-17 Resumed H.C. Wainwright Buy
Oct-07-16 Initiated H.C. Wainwright Buy
Jul-22-15 Initiated ROTH Capital Buy
Jun-23-15 Initiated Canaccord Genuity Buy
View All

Lipocine Inc Stock (LPCN) Latest News

pulisher
04:10 AM

Pattern recognition hints at Lipocine Inc. upsideEquity Portfolio Outlook and Performance Summary - Newser

04:10 AM
pulisher
12:55 PM

Using fundamentals and technicals on Lipocine Inc.Swing Watchlist With Tight Stop Placement - Newser

12:55 PM
pulisher
Aug 01, 2025

Historical volatility pattern of Lipocine Inc. visualizedSwing Trade Timing with Daily Forecast - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Tools to assess Lipocine Inc.’s risk profileDaily Market Momentum and Pressure Analysis - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

When is the best time to exit Lipocine Inc.Short-Term Support and Resistance Forecast - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Is Lipocine Inc. a candidate for recovery playShort Term Gain Strategy with AI Logic - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

What are Lipocine Inc. company’s key revenue driversBreakout Stocks Tracker With High Returns - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

What makes Lipocine Inc. stock price move sharplyLow Risk Alerts Backed By Experts - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Real time alert setup for Lipocine Inc. performanceMachine Learning Stock Movement Detector - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Why is Lipocine Inc. stock attracting strong analyst attentionAdvanced Screener Data Feed To Watch Now - jammulinksnews.com

Aug 01, 2025
pulisher
Jul 31, 2025

Is Lipocine Inc. reversing from oversold territorySwing Trade Signal and Price Prediction - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Does Lipocine Inc. stock perform well during market downturnsBeginner Investor Planner With High Returns - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Using flow based indicators on Lipocine Inc.Real Time Trade Execution Alert Plan - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Candlestick signals on Lipocine Inc. stock todayLong-Term Signal Tracking and Profit Summary - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Momentum Indicator Shows Bearish Divergence in Lipocine Inc.AI Forecast for Trending Stocks Indicates Upside - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Lipocine Inc. Recovers — But Is It SustainableOptimized Watchlist With Daily Adjustments Launched - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Price Consolidation Hints at Upcoming Move in Lipocine Inc.Multi-Bagger Potential Stock Forecast Tools Released - beatles.ru

Jul 29, 2025
pulisher
Jul 28, 2025

RSI + MACD Show Convergence for Lipocine Inc.AI Screening for Swing Trade Picks Finds Momentum - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Chartists See Breakout Potential in Lipocine Inc.Verified Signal From Chart Patterns Detected - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is Lipocine Inc. company’s balance sheetFree Risk Assessment Services - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Lipocine Inc. stockBuild a diversified portfolio for risk management - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Lipocine Inc. stock overvalued or undervaluedSuperior investment outcomes - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is Lipocine Inc. company’s growth strategyConsistently superior profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Lipocine Inc.Skyrocketing investment returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Lipocine Inc. stock compared to the marketMarket-leading growth rates - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is Lipocine Inc. stock expected to show significant growthAccelerated wealth building - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Should I hold or sell Lipocine Inc. stock in 2025Stay ahead with advanced stock screening tools - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How Resilient Is Lipocine Inc. Stock During Economic DownturnsSafe High Return Entry Points - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Lipocine Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree AI-Powered Stock Predictions - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Intrinsic Value of Lipocine Inc. Stock: Is It Undervalued or Overvalued3x Return Stock Radar - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Moving Average Trends for Lipocine Inc. Stock: What They IndicateLow Risk Stock Strategies - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Lipocine Inc. stock performs during market volatilityFree VIP Group - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

What analysts say about Lipocine Inc. stockHigh-impact stock picks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Lipocine Inc. stock priceUnstoppable investment returns - Autocar Professional

Jul 25, 2025
pulisher
Jul 23, 2025

Is Lipocine Inc. a good long term investmentFree Wealth Planning Blueprint - Autocar Professional

Jul 23, 2025

Lipocine Inc Stock (LPCN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):